William Blair Upgrades Akari Therapeutics (AKTX) to Outperform
Tweet Send to a Friend
William Blair upgraded Akari Therapeutics (NASDAQ: AKTX) from Market Perform to Outperform.Analyst Tim Lugo notes the PNH program ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
